Related Experiment Videos

Interleukin-2 in therapy of hematologic malignancies

M Sznol, D R Parkinson

|April 15, 1994

Summary

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Antitumor activity of ipilimumab or BRAF ± MEK inhibition after pembrolizumab treatment in patients with advanced melanoma: analysis from KEYNOTE-006.

Annals of oncology : official journal of the European Society for Medical Oncology·2021

Changes in serum interleukin-8 (IL-8) levels reflect and predict response to anti-PD-1 treatment in melanoma and non-small-cell lung cancer patients.

Annals of oncology : official journal of the European Society for Medical Oncology·2017

A Variant in a MicroRNA complementary site in the 3' UTR of the KIT oncogene increases risk of acral melanoma.

Oncogene·2010

Educating for personalized medicine: a perspective from oncology.

Clinical pharmacology and therapeutics·2009

Anticancer drug discovery and development throughout the world.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2002

A prospective randomized phase II trial of GM-CSF priming to prevent topotecan-induced neutropenia in chemotherapy-naive patients with malignant melanoma or renal cell carcinoma.

Blood·2001

See all related articles